Information, support and friendship
AMEND, AMEND USA, AMEND Australia and AMEND New Zealand are all run by patients, for patients, to inform and support anyone affected by Multiple Endocrine Neoplasia (MEN) types 1, 2 and 3 and associated endocrine syndromes and tumours.
We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our 'family'.
The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on MEN1, MEN2, MEN3, MTC (medullary thyroid cancer), FMTC (familial medullary thyroid cancer), adrenal gland tumours (phaeochromocytomas), parathyroid hyperplasia, paragangliomas, FIPA (familial isolated pituitary adenoma) and SDHx (succinate dehydrogenase) disorders.
MEN patient perspective films
Updated Info on MEN2a
We are pleased to announce that our 2015 updated UK version of our popular Information Book on MEN2a is now available to download from this site. The updated booklet now includes a glossary and many other improvements.
August 2015 Newsletter
AMEND's latest newsletter (Issue 49) is now available to registered members to view and download on this site. Please remember to log in! Registration is free, so click here to become a member of AMEND and to access the latest newsletter. Hear about our 2015 Summer Intern's experience, our 2015 Research Awards totalling £50,000, and much, much more.
Page 1 of 18